Stock MTAC MEDH ACQU
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

MEDH ACQU

Equities

MTAC

US58507N1054

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration

Latest news about MEDH ACQU

MedTech Acquisition, TriSalus Life Sciences Complete Merger MT
MedTech Acquisition Corporation(NasdaqCM:MTAC) dropped from NASDAQ Composite Index CI
Trisalus Life Sciences Inc. completed the acquisition of MedTech Acquisition Corporation from Medtech Acquisition Sponsor LLC, Magnetar Financial LLC and others. CI
Top Premarket Gainers MT
MedTech Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
MedTech Acquisition Corporation announced that it has received $0.137375 million in funding CI
TriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases At the Asco 2023 Annual Meeting CI
MedTech Acquisition Corporation announced that it expects to receive $17.85502 million in funding CI
MedTech Acquisition Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
MedTech Acquisition Corporation Auditor Raises 'Going Concern' Doubt CI
Magnetar Capital Engages in Discussions with MedTech Acquisition Corporation CI
MedTech Acquisition Corporation announced that it has received $1.468821 million in funding from Medtech Acquisition Sponsor LLC CI
TriSalus Life Sciences Highlights Pressure-Enabled Regional Immuno-Oncologyâ„¢ (PERIOâ„¢) Clinical Trial Progress and Pre-clinical Research Developments CI
TriSalus Life Sciences to Merge With MedTech Acquisition to Go Public MT
Trisalus Life Sciences Inc. entered into a definitive merger agreement to acquire MedTech Acquisition Corporation from Medtech Acquisition Sponsor LLC, Magnetar Financial LLC and others for $220 million in a reverse merger transaction. CI
MedTech Acquisition Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
MedTech Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
MedTech Acquisition Corporation announced that it has received $1.5 million in funding from Medtech Acquisition Sponsor LLC CI
MedTech Acquisition Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
MedTech Acquisition, Memic Innovative Surgery Agree to Terminate Merger Agreement MT
Memic Innovative Surgery Ltd. cancelled the acquisition of MedTech Acquisition Corporation from a group of sellers in a reverse merger transaction. CI
MedTech Acquisition Corporation Announces Board Changes CI
MedTech Acquisition Corporation Reports Earnings Results for the Full Year Ended December 31, 2021 CI
MedTech Acquisition Corporation Auditor Raises 'Going Concern' Doubt CI
MedTech Acquisition Corporation Announces Management Changes CI

Chart MEDH ACQU

Chart MEDH ACQU
More charts

Company Profile

MedTech Acquisition Corporation is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus on businesses primarily operating in the healthcare sector in the United States. The Company has not commenced any business operations and has not generated any revenue.
Sector
-
More about the company
  1. Stock Market
  2. Equities
  3. MTAC Stock
  4. News MEDH ACQU
  5. MedTech Acquisition : Memic Innovative Surgery to Go Public via $1 Billion SPAC Deal with MedTech Acquisition